Sometimes you come across stocks that are just perfect, companies that seem to be doing everything right, growing revenue and earnings at strong double-digit rates and projecting solid sales and earnings growth ahead. Brokers just love these stocks and end up raising their estimates on them. But even with all these positives, for some reason, prices remain reasonable. There seems to be no reason to remain at the sidelines then. So it makes perfect sense to dive right in-

Malibu Boats, Inc. (MBUU Quick QuoteMBUU - Free Report)

Malibu Boats, Inc. operates as a designer, manufacturer and marketer of sport boats primarily in the United States. The Company sells its boats under two brands: Malibu and Axis Wake Research. Its sport boats used for water sports including water skiing, wakeboarding and wake surfing as well as for general recreational boating use.

Average broker rating 1

Zacks Rank #1 (Strong Buy)

VGM score A

Sales growth in the last fiscal year ending June was 76.28%

Expected sales growth this year 35.85% and next year 12.50%

EPS growth in the last fiscal year was 66.67%

Expected EPS growth this year 40.00% and next year 13.74%

Fiscal 2019 EPS estimate up 4.30%, 2020 EPS up 2.73% in the last 60 days

Valuation: The forward 12 months’ P/E of 9.08X trails the 16.69X for the S&P 500

MEDIFAST INC (MED Quick QuoteMED - Free Report)

Medifast is a leading manufacturer and distributor of clinically proven weight loss and healthy living products and programs. Distribution is through websites, telemarketing, franchised weight loss clinics, medical professionals and multi-level marketing.

Average broker rating 1

Zacks Rank #2 (Buy)

VGM score B

Sales growth in the last fiscal year was 66.14%

Expected sales growth this year 47.72% and next year 24.98%

EPS growth in the last fiscal year was 101.75%

Expected EPS growth this year 47.19% and next year 26.91%

Valuation: The forward 12 months’ P/E of 18.25X trails the 16.69X for the S&P 500. But whereas the S&P 500 is trading at its median value, MED is trading well below its median value of 23.68X.

OptimizeRx Corp. (OPRX Quick QuoteOPRX - Free Report)

OptimizeRx Corporation provides marketing and advertising solutions that seek to increase patient awareness and education about its clients’ brands and then helps patients adhere to their routines. It is believed that this approach, facilitated through a platform connecting patients, physicians and pharmaceutical manufacturers, ultimately lowers cost for patients.

Average broker rating 1

Zacks Rank #1

Growth score A

Sales growth in the last fiscal year was 74.87%

Expected sales growth this year 35.17% and next year 29.65%

EPS growth in the last fiscal year was 223.8%

Expected EPS growth this year 61.54% and next year 55.16%

Valuation: The forward 12 months’ P/E of 49.73X is below its median value of 90.67X and is at a significantly higher level than the S&P 500.

Synergy Resources Corporation

SRC Energy Inc. is an oil and natural gas exploration and production company. It engages in the acquisition, development, exploitation, exploration and production of oil and natural gas properties, primarily located in the Wattenberg field in the D-J Basin of northeast Colorado.

Average broker rating 1.4

Zacks Rank #2

VGM score A

Sales growth in the last fiscal year was 78.1%

Expected sales growth this year 18.27% and next year 10.22%

EPS growth in the last fiscal year was 63.77%

Expected EPS growth this year -11.50% and next year 14.79%

Valuation: The forward 12 months’ P/E of 4.07X is below its median value of 5.82X and trails the S&P 500

Pioneer Natural Resources Company

Pioneer Natural Resources Company is a large, Texas-based independent exploration and production company that is focused on helping to meet the world's energy needs. Pioneer Natural Resources deliver industry-leading production and reserve growth through onshore, unconventional, oil and gas resource development in the United States, while providing opportunities for growth and enrichment for business partners, employees and the communities in which operate. The company provides administrative, financial and management support to United States and foreign subsidiaries that explore for, develop and produce oil, natural gas liquid and natural gas reserves.

Average broker rating 1.19

Zacks Rank #2

VGM score B

Sales growth in the last fiscal year was 72.59%

Expected sales growth this year 6.86% and next year 13.16%

EPS growth in the last fiscal year was 192.13%

Expected EPS growth this year 48.81% and next year 18.69%

Valuation: The forward 12 months’ P/E of 14.18X is below its median value of 17.17X and trails the S&P 500.

Also see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>